Work

Supplementary Figures 1 - 2 from BH3 Profiling Discriminates Response to Cytarabine-Based Treatment of Acute Myelogenous Leukemia

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 79K, Supplementary Figure 1. BH3 Profiling representative patient data; Supplementary Figure 2. BH3 Profiling for BH3 Peptides in AML NR and CR Patients.

DOI: 10.1158/1535-7163.22500943.v1

Authors: William E. Pierceall, Steven M. Kornblau, Nicole E. Carlson, Xuelin Huang, Noel Blake, Ryan Lena, Michael Elashoff, Marina Konopleva, Michael H. Cardone, Michael Andreeff

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362621633

Cites:

Cited by:

Related to: 10